Clinical trial

Dextenza vs Prednisolone Acetate After Cataract Surgery for Patients With Diabetes

NCT04977427

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2021-08-31

PhasePHASE4

Study timeline

Study start (actual)2021-08-31Date precision: day

Registry last updated2026-03-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Cataract Diabeticunresolved

Macula Edemaunresolved

Interventions

Dextenza 0.4Mg Ophthalmic InsertDRUG

Prednisolone Acetate 1% Oph SuspDRUG

Sponsors & collaborators

Baylor Research Institutelead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04977427 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.